Get started
Author

Sophia A. Paxton

Observed names: S Paxton, Sophia Paxton
ORCID: 0009-0000-8169-6895
Observed ORCID: 0009-0000-8169-6895
OpenAlex ID: A5117232170
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
2026 · Elizabeth A. R. Garfinkle, Renzo Perales-Linares, et al. · Nature Cancer · 7
Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings
2025 · Mariam T. Mathew, Samara L. Potter, et al. · JCO Precision Oncology · 3
Ctim-33. Personalized Multivalent Dna Vaccination Safely Induces Broad Neoantigen-specific T Cell Responses in Newly Diagnosed Mgmt Unmethylated Glioblastoma in a Clinically Relevant Time Scale
2025 · Elizabeth Garfinkle, Renzo Perales-Linares, et al. · Neuro-Oncology · 1
PDF
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
2026 · Elizabeth A. R. Garfinkle, Renzo Perales-Linares, et al. · Nature Cancer
PDF
Abstract 7767: Spatial profiling of the tumor immune microenvironment following oncolytic herpes simplex virus treatment in glioblastoma
2026 · Sophia A. Paxton, Corinne H. Strawser, et al. · Cancer Research
NA
2026 · E Garfinkle, E Garfinkle, et al. · immuneACCESS
Abstract 6615: Uncovering the landscape of cellular heterogeneity in low- and high-grade endometrial cancer using single cell profiling
2025 · Sabina I. Swierczek, Elizabeth A. Garfinkle, et al. · Cancer Research
Works count: 7
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type